These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Early-onset Lafora body disease. Turnbull J; Girard JM; Lohi H; Chan EM; Wang P; Tiberia E; Omer S; Ahmed M; Bennett C; Chakrabarty A; Tyagi A; Liu Y; Pencea N; Zhao X; Scherer SW; Ackerley CA; Minassian BA Brain; 2012 Sep; 135(Pt 9):2684-98. PubMed ID: 22961547 [TBL] [Abstract][Full Text] [Related]
8. Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances. Zimmern V; Minassian B Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397161 [TBL] [Abstract][Full Text] [Related]
9. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all. Delgado-Escueta AV; Bourgeois BF Epilepsia; 2008 Dec; 49 Suppl 9():13-24. PubMed ID: 19087113 [TBL] [Abstract][Full Text] [Related]
10. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711 [TBL] [Abstract][Full Text] [Related]
11. Advances in the genetics of progressive myoclonus epilepsy. Delgado-Escueta AV; Ganesh S; Yamakawa K Am J Med Genet; 2001; 106(2):129-38. PubMed ID: 11579433 [TBL] [Abstract][Full Text] [Related]
12. The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy. Orsini A; Valetto A; Bertini V; Esposito M; Carli N; Minassian BA; Bonuccelli A; Peroni D; Michelucci R; Striano P Seizure; 2019 Oct; 71():247-257. PubMed ID: 31476531 [TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene]. de Haan GJ; Halley DJ; Deelen WH; Lindhout D Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222 [TBL] [Abstract][Full Text] [Related]
16. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations. Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460 [TBL] [Abstract][Full Text] [Related]
17. Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India. Sinha S; Satishchandra P; Gayathri N; Yasha TC; Shankar SK J Neurol Sci; 2007 Jan; 252(1):16-23. PubMed ID: 17166519 [TBL] [Abstract][Full Text] [Related]
18. Chronic neuronopathic type of Gaucher's disease with progressive myoclonic epilepsy in the absence of visceromegaly and bone involvement. Botross NP; Riad AA; Viswanathan S; Nordin RB; Lock HN Scott Med J; 2014 May; 59(2):e1-6. PubMed ID: 24671628 [TBL] [Abstract][Full Text] [Related]